Kynam Capital discloses 1.49M enGene (ENGN) shares stake
Rhea-AI Filing Summary
Kynam Capital Management and related reporting persons disclose a 2.23% beneficial stake in enGene Holdings Inc. common shares on an amended Schedule 13G. They report beneficial ownership of 1,492,898 common shares, with shared voting and dispositive power and no sole voting or dispositive authority.
The filing names Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang as reporting persons and certifies the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of enGene.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in enGene (ENGN) does Kynam Capital report?
Kynam Capital and related reporting persons report beneficial ownership of 1,492,898 enGene common shares, representing 2.23% of the class. This stake is held with shared voting and dispositive power, and falls below the 5% threshold that typically triggers larger-holder reporting.
Who are the reporting persons in this enGene (ENGN) Schedule 13G/A?
The filing lists Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang as reporting persons. Each reports the same 1,492,898 shares with shared voting and dispositive power, and no sole voting or sole dispositive authority over the enGene common shares.
Is Kynam Capital’s enGene (ENGN) position intended to influence control of the company?
The certification states the securities were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of enGene. It also notes they are not held in connection with any transaction having that control-related purpose or effect.
Why is this enGene (ENGN) ownership reported on Schedule 13G/A instead of 13D?
Schedule 13G is used for passive beneficial ownership, where investors do not seek to influence control. The filing’s certification confirms the enGene shares are held in the ordinary course of business and not to change or influence control, which aligns with Schedule 13G reporting requirements.